Hansoh Pharmaceutical Group Company Limited (HKG:3692)
37.30
-1.52 (-3.92%)
Aug 20, 2025, 9:29 AM HKT
HKG:3692 Revenue
In the year 2024, Hansoh Pharmaceutical Group Company had annual revenue of 12.26B CNY with 21.35% growth. Hansoh Pharmaceutical Group Company had revenue of 5.76B in the half year ending December 31, 2024, with 16.32% growth.
Revenue
12.26B CNY
Revenue Growth
+21.35%
P/S Ratio
15.97
Revenue / Employee
1.36M CNY
Employees
8,989
Market Cap
230.82B HKD
Revenue Chart
* This company reports financials in CNY.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 12.26B | 2.16B | 21.35% |
| Dec 31, 2023 | 10.10B | 721.40M | 7.69% |
| Dec 31, 2022 | 9.38B | -552.73M | -5.56% |
| Dec 31, 2021 | 9.94B | 1.24B | 14.33% |
| Dec 31, 2020 | 8.69B | 7.49M | 0.09% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| BeOne Medicines | 35.81B |
| JD Health International | 71.34B |
| Innovent Biologics | 10.03B |
| Akeso | 2.26B |
| Sino Biopharmaceutical | 30.72B |
| WuXi Biologics | 19.87B |
| CSPC Pharmaceutical Group | 28.99B |
| Sichuan Kelun-Biotech Biopharmaceutical | 2.06B |